CPPG结构式
|
常用名 | CPPG | 英文名 | CPPG |
|---|---|---|---|---|
| CAS号 | 183364-82-1 | 分子量 | 271.20600 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C11H14NO5P | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS07 |
信号词 | Warning |
CPPG用途CPPG ((RS)-CPPG) 是一种有效的 II/III 型 mGlu 受体拮抗剂。CPPG 对大鼠大脑皮层中的 III 组 (IC50=2.2 nM) 比对 II 组((IC50=46.2 nM) mGlu 受体有一定的选择性 (约 20 倍)。CPPG 对 I 组 mGlu 受体的作用较弱。 |
| 英文名 | CPPG,(RS)-α-Cyclopropyl-4-phosphonophenylglycine |
|---|---|
| 英文别名 | 更多 |
| 描述 | CPPG ((RS)-CPPG) 是一种有效的 II/III 型 mGlu 受体拮抗剂。CPPG 对大鼠大脑皮层中的 III 组 (IC50=2.2 nM) 比对 II 组((IC50=46.2 nM) mGlu 受体有一定的选择性 (约 20 倍)。CPPG 对 I 组 mGlu 受体的作用较弱。 |
|---|---|
| 相关类别 | |
| 体外研究 | CPPG((RS)-CPPG能同时逆转L-AP4(IC50=2.2nm)和L-CCG-I(IC50=46.2nm)介导的forskolin刺激的成年大鼠皮层脑片环腺苷酸积累的抑制作用。CPPG是抗成年大鼠皮层II/III型mGlu受体的有效拮抗剂,对III型mGlu受体具有中等的选择性。相反,CPPG对新生大鼠皮层和培养的小脑颗粒细胞中的mGlu受体的作用较弱[1]。 |
| 参考文献 |
| 分子式 | C11H14NO5P |
|---|---|
| 分子量 | 271.20600 |
| 精确质量 | 271.06100 |
| PSA | 130.66000 |
| LogP | 0.83850 |
| InChIKey | IGODGTDUQSMDQU-UHFFFAOYSA-N |
| SMILES | NC(C(=O)O)(c1ccc(P(=O)(O)O)cc1)C1CC1 |
|
Examination of VLC-PUFA-deficient photoreceptor terminals.
Invest. Ophthalmol. Vis. Sci. 55(7) , 4063-72, (2014) Juvenile-onset autosomal dominant Stargardt-like macular dystrophy (STGD3) is caused by mutations in ELOVL4 (elongation of very long fatty acids-4), an elongase necessary for the biosynthesis of very ... |
|
|
Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies.
Neuropharmacology 102 , 276-94, (2016) In the present study, we investigated the effect of ACPT-I [(1S, 3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid], a blood-brain-barrier permeable agonist of group III mGlu receptor, against oxyge... |
|
|
Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action.
Neuropharmacology 85 , 166-77, (2014) Metabotropic glutamate 4 (mGlu4) receptor is a promising target for the treatment of motor deficits in Parkinson's disease (PD). This is due in part to its localization at key basal ganglia (BG) synap... |
|
实验名称:qHTS for Inhibitors of Polymerase Kappa
来源:NCGC
靶标:DNA polymerase kappa [Homo sapiens]
External Id:PolK100
|
|
实验名称:Cell-based high throughput primary assay to identify activators of GPR151
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id:GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify activators of...
来源:The Scripps Research Institute Molecular Screening Center
靶标:N/A
External Id:FBW7_ACT_ALPHA_1536_1X%ACT PRUN
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
来源:The Scripps Research Institute Molecular Screening Center
External Id:MITF_INH_Alpha_1536_1X%INH PRUN
|
|
实验名称:qHTS for Inhibitors of binding or entry into cells for Marburg Virus
来源:NCGC
靶标:gene 4 small orf - Marburg virus
External Id:VSVM-OFFLINE
|
|
实验名称:Rat mGlu8 receptor (Metabotropic glutamate receptors)
来源:IUPHAR-DB
靶标:mGlu8 receptor (Metabotropic glutamate receptors) [Rattus norvegicus]
External Id:296_Rat
|
|
实验名称:qHTS for Inhibitors of binding or entry into cells for Lassa Virus
来源:NCGC
靶标:N/A
External Id:VSVL-OFFLINE
|
| CPPG |
| Water,sterile filtered |